HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

EVH

Evolent Health, Inc. (NYSE)

Healthcare — Health Information Services

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Buy 1.7 / 5 13 analysts
$5.74
+$0.32 (+5.90%)
Target: $5.88 (2.5%)
Sign in to add EVH to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$645.64M
P/E Ratio (TTM)-
Forward P/E14.91
EPS (TTM)$-4.68
Dividend Yield-
Profit Margin-26.29%
Revenue Growth2.60%
ROE-65.11%
Debt/Equity248.60
Recommendation Buy 1.7
Analyst Target$5.88
Analysts13
Indexes NYSE

Technical Indicators

RSI (14)74.3
Beta0.83
SMA 20-
SMA 40-
52-Week High$12.07
52-Week Low$2.10
50-Day Avg$4.20
200-Day Avg$4.49
Avg Volume$2.71M
Volume$2.39M

Performance Analysis

NEUTRAL

EVH presents a mixed picture with both positive and negative indicators.

~ Trading at 37% of its 52-week range.
- RSI at 74.3 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 2.6% year-over-year.
- Operating at a loss with -26.3% margin.
+ Wall Street consensus is "Buy" from 13 analysts.
+ Average analyst target of $5.88 implies 2.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:08 UTC

Back to Screener Export Report